Mode
Text Size
Log in / Sign up
N/A N=130 Randomized Treatment

Increasing Cardiac Rehabilitation Participation Among Medicaid Enrollees

Coronary Artery Disease

Enrolled (actual)
130
Serious AEs
40.8%
Results posted
Jun 2019
Primary outcome: Primary: Attendance at Cardiac Rehabilitation Exercise Sessions — 36; 19 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Financial incentives (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of Vermont
Primary completion
Jul 2017

Outcome Measures

OutcomeResultp-value
PRIMARY
Attendance at Cardiac Rehabilitation Exercise Sessions
36; 19
SECONDARY
Change in Physical Health
0.53; 1.87; 6.33; 12.54; -1.12; -0.23
SECONDARY
Changes in Mental Health/Cognition
-2.03; 1.03; 3.03; 16.10; -6.23; 0.97

Summary

Participation in outpatient cardiac rehabilitation (CR) decreases morbidity and mortality for patients hospitalized with myocardial infarction, coronary bypass surgery or percutaneous revascularization. Unfortunately, only 10-35% of patients for whom CR is indicated choose to participate. Medicaid coverage and similar state-supported insurance are robust predictors of CR non-participation. There is growing recognition of the need to increase CR among patients with this form of insurance and other economically disadvantaged patients, but there are no evidence-based interventions available for doing so. In the present study we are examining the efficacy of using financial incentives for increasing CR participation among Medicaid patients. Financial incentives have been highly effective in altering other health behaviors among disadvantaged populations (e.g., smoking during pregnancy, weight loss). For this study are randomizing 130 CR-eligible Medicaid enrollees to a treatment condition where they receive financial incentives contingent on initiation of and continued attendance at CR sessions or to a "usual-care" condition where they will not receive these incentives. Treatment conditions will be compared on attendance at CR and end-of-intervention improvements in fitness, decision making and health-related quality of life. Cost effectiveness of the treatment conditions will also be examined by comparing the costs of the incentive intervention and usual care conditions with their effects on increasing CR initiation and adherence. Should this intervention be efficacious and cost-effective, it has the potential to substantially increase CR participation and significantly improve health outcomes among low-income cardiac patients.

Eligibility Criteria

Inclusion Criteria

  • A recent myocardial infarction, percutaneous coronary intervention, coronary artery bypass graft, heart valve replacement or repair, or stable heart failure.
  • Enrolled in a state-supported insurance plan for low income individuals
  • Lives in and plans to remain in the greater Burlington, Vermont area (Chittenden County) for the next 12 mos.

Exclusion criteria

  • Dementia (MMSE<20) or current untreated Axis 1 psychiatric disorder other than nicotine dependence as determined by medical history
  • Non-English speaking
  • Prior participation in cardiac rehabilitation
  • Advanced cancer, advanced frailty, or other longevity-limiting systemic disease that would preclude CR participation
  • Rest angina or very low threshold angina (<2 METS) until adequate therapy is instituted
  • Severe life threatening ventricular arrhythmias unless adequately controlled (e.g. intracardiac defibrillator)
  • Class 4 chronic heart failure (symptoms at rest)
  • Exercise-limiting non-cardiac disease such as severe arthritis, past stroke, severe lung disease
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02172820). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search